Author:
Misawa Kiyoshi,Misawa Yuki,Mima Masato,Yamada Satoshi,Imai Atsushi,Mochizuki Daiki,Nakagawa Takuya,Kurokawa Tomoya,Endo Shiori,Kawasaki Hideya,Brenner John Chadwick.,Mineta Hiroyuki
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Molecular Medicine,General Medicine
Reference45 articles.
1. M.R. Migden, D. Rischin, C.D. Schmults, A. Guminski, A. Hauschild, K.D. Lewis, C.H. Chung, L. Hernandez-Aya, A.M. Lim, A.L.S. Chang, G. Rabinowits, A.A. Thai, L.A. Dunn, B.G.M. Hughes, N.I. Khushalani, B. Modi, D. Schadendorf, B. Gao, F. Seebach, S. Li, J. Li, M. Mathias, J. Booth, K. Mohan, E. Stankevich, H.M. Babiker, I. Brana, M. Gil-Martin, J. Homsi, M.L. Johnson, V. Moreno, J. Niu, T.K. Owonikoko, K.P. Papadopoulos, G.D. Yancopoulos, I. Lowy, M.G. Fury, PD-1 Blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma. N Engl J Med 379, 341–351 (2018)
2. T. Kanazawa, K. Misawa, Y. Misawa, T. Uehara, H. Fukushima, G. Kusaka, M. Maruta, T.E. Carey, G-protein-coupled receptors: Next generation therapeutic targets in head and neck cancer? Toxins (Basel) 7, 2959–2984 (2015)
3. M. Mikulandra, A. Kobescak, B. Verillaud, P. Busson, T. Matijevic Glavan, Radio-sensitization of head and neck cancer cells by a combination of poly(I:C) and cisplatin through downregulation of survivin and c-IAP2. Cell Oncol 42, 29–40 (2019)
4. S. Roy, M. Kar, A. Saha, S. Padhi, B. Banerjee, Role of beta-catenin in cisplatin resistance, relapse and prognosis of head and neck squamous cell carcinoma. Cell Oncol 41, 185–200 (2018)
5. V. Budach, I. Tinhofer, Novel prognostic clinical factors and biomarkers for outcome prediction in head and neck cancer: A systematic review. Lancet Oncol 20, e313–e326 (2019)
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献